PNC Financial Services Group’s Immunic IMUX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q3
Sell
-30
Closed -$4K 4349
2021
Q2
$4K Hold
30
﹤0.01% 3928
2021
Q1
$5K Hold
30
﹤0.01% 3818
2020
Q4
$5K Hold
30
﹤0.01% 3706
2020
Q3
$6K Buy
+30
New +$4.91K ﹤0.01% 3631

Other funds holding IMUX

PNC Financial Services Group's IMUX Position: Q3 2021 in Review

PNC Financial Services Group sold out of Immunic (IMUX) in Q3 2021, closing a stake of 30 shares — an estimated $4K sold.

PNC Financial Services Group first reported a position in IMUX in Q3 2020 and held it in 4 quarters. The position peaked at $6K in Q3 2020. 68 funds tracked by Wall St. Rank hold IMUX as of Q3 2021.

  • PNC Financial Services Group reported no remaining Immunic position as of Q3 2021 after selling out during the quarter.
  • PNC Financial Services Group sold 30 Immunic shares in Q3 2021, an estimated $4K.
  • PNC Financial Services Group first reported a position in Immunic in Q3 2020 and held it in 4 quarters.
  • PNC Financial Services Group's Immunic position peaked at $6K in Q3 2020.
  • 68 funds tracked by Wall St. Rank held Immunic as of Q3 2021.

Based on PNC Financial Services Group's 13F filing for Q3 2021, filed 5 Nov 2021.